Jacob Silterra

13.7k total citations
8 papers, 270 citations indexed

About

Jacob Silterra is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Jacob Silterra has authored 8 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Jacob Silterra's work include Pancreatic and Hepatic Oncology Research (2 papers), Pneumonia and Respiratory Infections (2 papers) and Cancer Genomics and Diagnostics (2 papers). Jacob Silterra is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Pneumonia and Respiratory Infections (2 papers) and Cancer Genomics and Diagnostics (2 papers). Jacob Silterra collaborates with scholars based in United States, Spain and Sweden. Jacob Silterra's co-authors include Jill P. Mesirov, Edoardo M. Airoldi, Bang Wong, Yarden Katz, Christopher B. Burge, Schraga Schwartz, James Robinson, Helga Thorvaldsdóttir, Eric T. Wang and Dyann F. Wirth and has published in prestigious journals such as Bioinformatics, American Journal of Respiratory and Critical Care Medicine and Cancer Research.

In The Last Decade

Jacob Silterra

8 papers receiving 264 citations

Peers

Jacob Silterra

MB

CR

PHEOH

EPIDE

ONCOL

Jorrit Boekel Sweden

Amaia González‐Magaña Spain

Yongfeng Li China

Jiewei Xu United States

Ana Lía Nocito Argentina

Elya Dekel Israel

Jeffrey R. Johnson United States

Si’Ana A. Coggins United States

Sanqi An China

Bharanidharan Devarajan India

Jorrit Boekel Sweden

Jacob Silterra

265 ×1.7

MB

48 ×0.8

CR

18 ×0.5

PHEOH

61 ×1.8

EPIDE

19 ×0.6

ONCOL

Citations per year, relative to Jacob Silterra Jacob Silterra (= 1×) peers Jorrit Boekel

Countries citing papers authored by Jacob Silterra

Since Specialization

Citations

This map shows the geographic impact of Jacob Silterra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Silterra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Silterra more than expected).

Fields of papers citing papers by Jacob Silterra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Silterra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Silterra. The network helps show where Jacob Silterra may publish in the future.

Co-authorship network of co-authors of Jacob Silterra

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Silterra. A scholar is included among the top collaborators of Jacob Silterra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Silterra. Jacob Silterra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Fabrizio, David, Daniel S. Lieber, Christine M. Malboeuf, et al.. (2018). Abstract 5706: A blood-based next-generation sequencing assay to determine tumor mutational burden (bTMB) is associated with benefit to an anti-PD-L1 inhibitor, atezolizumab. Cancer Research. 78(13_Supplement). 5706–5706. 28 indexed citations

2.

Fabrizio, David, Christine M. Malboeuf, Daniel S. Lieber, et al.. (2017). Analytic validation of a next generation sequencing assay to identify tumor mutational burden from blood (bTMB) to support investigation of an anti-PD-L1 agent, atezolizumab, in a first line non-small cell lung cancer trial (BFAST). Annals of Oncology. 28. v27–v27. 14 indexed citations

3.

Silterra, Jacob, Michael A. Gillette, Miguel Lanaspa, et al.. (2016). Transcriptional categorization of the etiology of pneumonia syndrome in pediatric patients in malaria endemic areas. The Journal of Infectious Diseases. 215(2). jiw531–jiw531. 10 indexed citations

4.

Katz, Yarden, Eric T. Wang, Jacob Silterra, et al.. (2015). Quantitative visualization of alternative exon expression from RNA-seq data. Bioinformatics. 31(14). 2400–2402. 127 indexed citations

5.

Valim, Clarissa, Rushdy Ahmad, Miguel Lanaspa, et al.. (2015). Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia. American Journal of Respiratory and Critical Care Medicine. 193(4). 448–459. 29 indexed citations

6.

Herman, Jonathan D., Daniel P. Rice, Ulf Ribacke, et al.. (2014). A genomic and evolutionary approach reveals non-genetic drug resistance in malaria. Genome Biology. 15(11). 511–511. 19 indexed citations

7.

Herman, Jonathan D., Daniel P. Rice, Ulf Ribacke, et al.. (2014). A genomic and evolutionary approach reveals non-genetic drug resistance in malaria. Genome biology. 15(11). 511–511. 34 indexed citations

8.

Silterra, Jacob, et al.. (2009). A compact soft X-ray microscope using an electrode-less Z-pinch source. Journal of Physics Conference Series. 186. 12028–12028. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact